Aegerion Pharmaceuticals, Inc. (AEGR) was a big mover last session, as its shares rose nearly 11% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This reverses the trend for the healthcare company since Feb 24, as the stock is now down nearly 19%.
In the last 30-day frame, the company witnessed seven negative estimate revisions and the Zacks Consensus Estimate also moved lower, signaling trouble down the road. So make sure to keep an eye on this stock going forward to see if yesterday’s move higher lasts.
Aegerion Pharmaceuticals currently has a Zacks Rank #3 (Hold) while its Earnings ESP is negative.
Other better-ranked stocks in the medical sector include Cambrex Corporation (CBM), Alkermes plc (ALKS) and Biogen Idec Inc. (BIIB). While Biogen Idec and Alkermes sport a Zacks Rank #1 (Strong Buy), Cambrex carries a Zacks Rank #2 (Buy).
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>
AEGERION PHARMACEUTICALS INC (AEGR): Free Stock Analysis Report
BIOGEN IDEC INC (BIIB): Free Stock Analysis Report
CAMBREX CORP (CBM): Free Stock Analysis Report
ALKERMES PLC ORD (ALKS): Free Stock Analysis Report
Zacks Investment Research
- Finance Trading
- Health Care Industry